Please see more information about our response to COVID-19

Ketamine for Depression

The Mental Health Stigma New Moms Face — And How These 10 Celebrity PPD Survivors Fight For Awareness

The mental health issues new moms experience after birth have long been stigmatized. What’s expected to be such a happy and joyous time when the new bundle of joy arrives, often feels anything but joyous. The excitement of nesting leading up to delivery may be replaced by anxiety or even [...]

By |2020-02-13T07:27:32+00:00October 31st, 2019|Categories: Ketamine for Depression, PPD|

What is SPRAVATO (esketamine)?

SPRAVATO - FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression According to the National Institute of Mental Health, depression is one of the most common mental health disorders among adults in the United States today, and a leading cause of both prescription drug usage and disability claims. An estimated 17 million [...]

By |2019-05-04T00:00:00+00:00May 4th, 2019|Categories: Ketamine for Depression|

FDA Approves Esetamine Treatment for Treatment-Resistant Depression

Breaking news: the FDA has approved the use of Esketamine—a low-dose nasal ketamine spray—for the treatment of depression, PTSD, and other mood disorders! FDA approval for Esketamine came less than one month after an FDA expert panel composed of psychiatrists and consumer representatives recommended (with nearly unanimous agreement) approval of [...]

By |2020-02-13T09:03:19+00:00April 1st, 2019|Categories: Ketamine for Depression|

SPRAVATO™ (esketamine) – Nasal Spray, Now FDA Approved‎

A Ketamine-Based Nasal Spray For Depression Has Just Been Approved by The FDA The Food and Drug Administration approved a novel antidepressant late Tuesday for people with depression that does not respond to other treatments - the first in decades to work in a completely new way in the brain. The drug, [...]

By |2019-03-18T00:00:00+00:00March 18th, 2019|Categories: Ketamine for Depression, Ketamine for Pain|

We monitor your depression levels before, during, and after Ketamine treatments

Ketamine Infusion Therapy for Depression: Short- and Long-Term Monitoring for Lasting Results Clinical depression is the second most common form of mental illness in the United States after anxiety disorders, and may impact as many as 16 million Americans annually. Clinical depression can be difficult to recognize at first; after [...]

By |2020-03-17T09:29:52+00:00March 10th, 2019|Categories: Ketamine for Depression|
error: Content is protected !!